Simplex Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,500
Closed -$45K 11964
2021
Q3
$45K Hold
5,500
﹤0.01% 7646
2021
Q2
$45K Buy
5,500
+5,445
+9,900% +$46.3K ﹤0.01% 7786
2021
Q1
$49K Sell
55
-12
-18% -$138 ﹤0.01% 6654
2020
Q4
$77K Buy
67
+24
+56% +$279 ﹤0.01% 5712
2020
Q3
$44K Sell
43
-67
-61% -$821 ﹤0.01% 5741
2020
Q2
$144K Buy
110
+33
+43% +$342 ﹤0.01% 4394
2020
Q1
$60K Sell
77
-157
-67% -$2.37K ﹤0.01% 4956
2019
Q4
$484K Buy
234
+34
+17% +$573 ﹤0.01% 2787
2019
Q3
$274K Buy
200
+120
+150% +$1.42K ﹤0.01% 3255
2019
Q2
$98K Buy
80
+21
+36% +$242 ﹤0.01% 4216
2019
Q1
$73K Buy
59
+20
+51% +$267 ﹤0.01% 4669
2018
Q4
$44K Buy
39
+31
+388% +$486 ﹤0.01% 4650
2018
Q3
$14K Sell
8
-9
-53% -$207 ﹤0.01% 6249
2018
Q2
$43K Sell
17
-112
-87% -$2.91K ﹤0.01% 5218
2018
Q1
$47K Buy
129
+23
+22% +$561 ﹤0.01% 2521
2017
Q4
$11K Sell
106
-95
-47% -$2.33K ﹤0.01% 3850
2017
Q3
$62K Sell
201
-208
-51% -$4.89K ﹤0.01% 2122
2017
Q2
$154K Buy
409
+212
+108% +$4.42K 0.01% 1403
2017
Q1
$18K Buy
197
+133
+208% +$2.71K ﹤0.01% 3380
2016
Q4
$7K Buy
64
+19
+42% +$363 ﹤0.01% 4118
2016
Q3
$3K Sell
45
-1
-2% -$17 ﹤0.01% 4786
2016
Q2
$5K Buy
46
+9
+24% +$113 ﹤0.01% 4313
2016
Q1
$2K Buy
37
+32
+640% +$388 ﹤0.01% 4862
2015
Q4
$3K Sell
5
-2
-29% -$35 ﹤0.01% 4350
2015
Q3
$8K Buy
+7
New +$164 ﹤0.01% 3675

Simplex Trading's FLXN Position: Q4 2021 in Review

Simplex Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 14,725 shares — an estimated $120K sold.

Simplex Trading first reported a position in FLXN in Q3 2015 and held it in 14 quarters. The position peaked at $1.11M in Q4 2019. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Simplex Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Simplex Trading sold 14,725 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $120K.
  • Simplex Trading first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 14 quarters.
  • Simplex Trading's Flexion Therapeutics, Inc. position peaked at $1.11M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.